# Drug Discovery
Latest news and articles about Drug Discovery
Total: 3 articles found
China’s Biotech Coming of Age: Hengrui and BMS Strike Record $15.2 Billion Alliance
Hengrui Pharmaceuticals and Bristol Myers Squibb have signed a landmark $15.2 billion strategic partnership to develop 13 early-stage drug candidates. The deal marks a record for Chinese biotech out-licensing and underscores the growing global reliance on Chinese innovation to replenish pharmaceutical pipelines.
OpenAI Steps into the Lab: GPT-Rosalind and the High-Stakes Battle for AI-Driven Cures
OpenAI has launched GPT-Rosalind, a specialized AI model for drug discovery, marking a direct challenge to Google's dominance in the life sciences sector. Partnering with industry leaders like Moderna and Amgen, OpenAI aims to leverage its generative technology to accelerate the translation of biological data into clinical medical applications.
The Algorithmic Apothecary: Insilico Medicine Nets High-Stakes AI Drug Pact with Eli Lilly
Insilico Medicine has entered a strategic collaboration with Eli Lilly to utilize generative AI for drug discovery, marking a significant milestone in the integration of AI into Big Pharma's R&D pipelines. The partnership validates Insilico's Pharma.AI platform and signals a broader industry shift toward algorithmic molecular design.